Kaushik Thakkar

Kaushik Thakkar is a Senior Scientist specializing in Translational Gene Therapy at Johnson & Johnson Innovative Medicine.14 He has a strong background in biomedical sciences, with expertise in protein bio-engineering technology and immuno-oncology.

Education and Research

Thakkar received his education from The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.1 As a researcher, he has focused on gene therapy and oncology, which is evident from his verified Google Scholar profile.2

Career Progression

Kaushik Thakkar's career has shown steady growth in the pharmaceutical industry:

1. He started his current position as Senior Scientist, Translational Gene Therapy at The Janssen Pharmaceutical Companies (part of Johnson & Johnson) on June 13, 2023.3
2. Prior to this role, he likely held other positions within Johnson & Johnson or related companies, given his expertise and current senior status.

Professional Interests and Contributions

Thakkar's work primarily revolves around:

• Gene therapy research and development
• Translational science in the field of oncology
• Protein bio-engineering technology

He appears to be actively involved in the development of targeted therapies for cancer patients. For instance, he has shared information about FDA approval for a targeted therapy for patients with genetically defined, locally advanced, or metastatic urothelial carcinoma.5

Location and Professional Network

Kaushik Thakkar is based in California, United States.4 His professional presence extends to various platforms:

• LinkedIn: username kaushiknthakkar
• Twitter: @KKAUSHIK13
• Google Scholar: verified profile showcasing his research publications

Through his work at Johnson & Johnson Innovative Medicine, Thakkar contributes to advancing gene therapy and oncology treatments, potentially making significant impacts in the field of medical science and patient care.